Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FEM1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RAB24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATIC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TACC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRAK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAD1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GUCD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JAK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP37 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2R1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCT4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDAC6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRCH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PFKL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSPA14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on